Advancing Bioequivalence Frameworks for Inhalation Drug Products
The Advancing Bioequivalence Frameworks for Inhalation Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods workshop, co-hosted by the U.S. Food and Drug Administration (FDA) and the Center […]